Andorra vs Jordan: Previously treated cases tested for RR-/MDR-TB
Andorra
100.0%
in 2014
Jordan
100.0%
in 2024
Andorra rank
1st
Jordan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Andorra
- Jordan
How they compare
Andorra currently reports 100.0% against 100.0% in Jordan, a difference of 0.0%.
The two have swapped places 1 time across 5 shared years of data; in 2006 it was Jordan ahead.
Andorra ranks 1st and Jordan ranks 1st of 180 countries.
Across the 2 decades both report, Andorra averaged higher in 1 and Jordan in 1.
Head to head by decade
| Decade | Andorra | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.7% | 78.3% | 61.7% | Jordan |
| 2010s | 100.0% | 24.0% | 76.0% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Andorra or Jordan?
- Andorra, at 100.0% against 100.0% in Jordan as of 2014.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Andorra and Jordan?
- 0.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Jordan?
- 5 years are reported by both, from 2006 to 2014.
- How do Andorra and Jordan rank globally for previously treated cases tested for rr-/mdr-tb?
- Andorra ranks 1st and Jordan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.